Bioengineering • AI • Neurotechnology
David
Charlot, PhD
Building technology that understands without destroying. From live cell analysis to AI-powered neurology—solving problems at the intersection of physics, biology, and human insight.
Philosophy
"Honor your ancestors. Make tomorrow better for your progeny.
Strength and Honor."
Chapter One
What I Build
Technology that looks without destroying, understands without reducing, and serves humanity across generations.
Live Cell Analysis
Non-destructive technology that studies cells without killing them— understanding disease through observation, not destruction.
AI for Neurology
Generative AI that automates neurological assessments— detecting patterns invisible to the human eye.
Resilient Systems
Infrastructure that adapts and responds—building technology that serves communities when they need it most.
Chapter Two
Ventures
From liquid biopsies to AI-powered neurology.
AuraSense Tech Corporation
Pioneering generative AI and automation for neurology assessments. Making advanced neurological care accessible and objective.
Visit siteCharlot Biosciences, Inc
CellPhoresis technology for non-destructive cell sorting. Live cell analysis without chemical tagging or lethal forces.
Visit siteOpen Interface Engineering, Inc
Energy-efficient AGI research and AI-native programming languages. Building sustainable artificial intelligence for the future.
Visit siteC3I Tech, LLC
Command, control, communications, and intelligence solutions. Resilient systems for critical infrastructure and defense.
Visit siteDJC Publishing
More than 350 titles spanning science fiction, children's adventures, AI philosophy, faith, and patent law. Independent publishing from manuscript to marketplace.
Visit siteChapter Three • Free to read · Free to hear
Every book, open to everyone
The books of David Jean Charlot, PhD, are free to read in your browser as pre-release editions: more than two hundred of them so far, with no account needed. Press Listen and a natural voice reads the chapter to you. It is one goal, simple to say and long to finish: to share reading with the world.
Open the readerEpilogue
Let's Connect
Whether you're interested in collaboration, speaking engagements, or just want to discuss the future of biotech and AI.
Get in Touch